Sana Biotechnology, Inc. (SANA)

Sana Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	71.27	127.57	133.52	176.77	253.03	124.81
Short-Term Investments	1.4	24.93	71.68	247.2	297.97	253.46
Cash & Short-Term Investments	72.67	152.5	205.2	423.96	551	378.26
Cash Growth	-71.12%	-25.68%	-51.60%	-23.05%	45.66%	172.17%
Prepaid Expenses	5.63	4.48	4.49	14.37	7.11	6.2
Restricted Cash	4.2	3.83	3.83	6.1	-	-
Total Current Assets	82.5	160.81	213.52	444.44	558.1	384.47
Property, Plant & Equipment	76.1	135.27	145.59	159.4	161.78	109.94
Long-Term Investments	-	-	-	10.05	195.88	33.73
Goodwill	140.63	140.63	140.63	140.63	140.63	140.63
Other Intangible Assets	59.2	59.2	59.2	59.2	59.2	59.2
Other Long-Term Assets	3.22	5.12	6.37	9.01	13.82	2.33
Total Assets	361.65	501.02	565.3	822.72	1,129	730.3
Accounts Payable	2.27	5.21	4.11	2.86	2.22	2.25
Accrued Expenses	17.34	27.39	37.98	39.12	28.91	22.59
Current Portion of Leases	13.83	12.83	13.2	12.39	9.16	3.71
Other Current Liabilities	-	-	9.2	57.14	58.95	2.89
Total Current Liabilities	33.44	45.43	64.49	111.5	99.24	31.45
Long-Term Leases	71.66	89.06	90.9	95.86	101.78	68.2
Other Long-Term Liabilities	133.99	116.02	122.41	116.04	199.89	198.94
Total Liabilities	239.09	250.52	277.79	323.41	400.91	298.58
Common Stock	0.02	0.02	0.02	0.02	0.02	0
Additional Paid-In Capital	1,871	1,855	1,626	1,558	1,515	8.22
Retained Earnings	-1,748	-1,605	-1,338	-1,055	-785.36	-429.43
Comprehensive Income & Other	-	0.01	-0.06	-4.33	-1.37	0.03
Total Common Equity	122.56	250.5	287.51	499.32	728.5	-421.18
Shareholders' Equity	122.56	250.5	287.51	499.32	728.5	431.71
Total Liabilities & Equity	361.65	501.02	565.3	822.72	1,129	730.3
Total Debt	85.49	101.9	104.1	108.25	110.94	71.91
Net Cash (Debt)	-12.82	50.6	101.1	325.76	635.93	340.09
Net Cash Growth	-	-49.95%	-68.97%	-48.77%	86.99%	272.57%
Net Cash Per Share	-0.05	0.22	0.52	1.73	3.82	26.13
Filing Date Shares Outstanding	237.81	225.02	220.45	191.35	185.18	177.43
Total Common Shares Outstanding	230.51	223.92	197.86	191.02	184.93	16.17
Working Capital	49.06	115.38	149.03	332.93	458.87	353.02
Book Value Per Share	0.53	1.12	1.45	2.61	3.94	-26.05
Tangible Book Value	-77.27	50.68	87.68	299.49	528.68	-621.01
Tangible Book Value Per Share	-0.34	0.23	0.44	1.57	2.86	-38.40
Machinery	46.64	57.79	54.77	64.76	49	30.59
Construction In Progress	-	40.34	26.33	1.71	1.39	8.32
Leasehold Improvements	39.06	33.34	31.36	34.43	33.85	15.6

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q